CD5 (C6A10), MMab
It is reported that the CD5 antigen is expressed in 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, it is mainly observed to be associated with T-cell reactions. The CD5 antigen also reacts with many T-cell leukemias, lymphomas, activated T cells, and some B cells mainly located in the mantle zone of normal lymph nodes. It has also been reported that the CD5 antigen is expressed in acute T-lymphoblastic leukemia (T-ALL), some chronic B-lymphocytic leukemias (B-CLL), and B- and T-cell lymphomas.
Intended Use
It is reported that the CD5 antigen is expressed in 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, it is mainly observed to be associated with T-cell reactions. The CD5 antigen also reacts with many T-cell leukemias, lymphomas, activated T cells, and some B cells mainly located in the mantle zone of normal lymph nodes. It has also been reported that the CD5 antigen is expressed in acute T-lymphoblastic leukemia (T-ALL), some chronic B-lymphocytic leukemias (B-CLL), and B- and T-cell lymphomas.
Storage & Validity
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.
Specifications
| Product Name | CD5 (C6A10), MMab |
| Clone | C6A10 |
| Catalog No. | CCM-0354 |
| Positive Site | Cytoplasm, Membrane |
| Applicable Tissue | Paraffin section |
| Pre-treatment | Heat retrieval |
| Format and Volume | Ready-to-use: 1mL, 3mL, 6mL Concentrated: 0.1mL, 0.2mL, 1mL |
Download
-
Intended Use
-
Specifications
Related Product
